[1] |
Neunert C,Terrell DR,Arnold DM,et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia[J]. Blood Adv,2019,3(23):3829-3866.
|
[2] |
Northup PG,Garcia‐Pagan JC,Garcia‐Tsao G,et al. Vascular Liver Disorders,Portal Vein Thrombosis,and Procedural Bleeding in Patients With Liver Disease:2020 Practice Guidance by the American Association for the Study of Liver Diseases[J]. Hepatology,2021,73(1):366-413.
|
[3] |
Harding DJ,Perera MT,Chen F,et al. Portal vein thrombosis in cirrhosis:Controversies and latest developments[J]. World J Gastroenterol,2015,21(22):6769-6784.
|
[4] |
Ikeda M,Sekimoto M,Takiguchi S,et al. High incidence of thrombosis of the portal venous system after laparoscopic splenectomy:a prospective study with contrast-enhanced CT scan[J]. Ann Surg,2005,241(2):208-216.
|
[5] |
de'Angelis N,Abdalla S,Lizzi V,et al. Incidence and predictors of portal and splenic vein thrombosis after pure laparoscopic splenectomy[J]. Surgery,2017,162(6):1219-1230.
|
[6] |
Guo B,Pan J,Shen Y,et al. Platelet's Rule of Change and Clinical Significance before and after Splenectomy[J]. Am Surg,2019,85(11):1288-1293.
|
[7] |
Zhang N,Yao Y,Xue W,et al. Early prophylactic anticoagulation for portal vein system thrombosis after splenectomy:A systematic review and meta-analysis[J]. Biomed Rep,2016,5(4):483-490.
|
[8] |
Loring LA,Panicek DM,Karpeh MS. Portal system thrombosis after splenectomy for neoplasm or chronic hematologic disorder:is routine surveillance imaging necessary?[J]. J Comput Assist Tomogr,1998,22(6):856-860.
|
[9] |
马婧嶔,颜志平. 门静脉系统血栓:从病因到治疗的研究进展[J]. 介入放射学杂志,2015,24(04):362-368.
|
[10] |
Berzigotti A,García-Criado A,Darnell A,et al. Imaging in clinical decision-making for portal vein thrombosis[J]. Nat Rev Gastroenterol Hepatol,2014,11(5):308-316.
|
[11] |
赵空军,申放. 螺旋CT增强扫描对门静脉癌栓与门静脉血栓的诊断价值[J]. 血栓与止血学,2022,28(03):442-443.
|
[12] |
McLendon K,Goyal A,Bansal P,et al. Deep Venous Thrombosis Risk Factors[M]. Treasure Island(FL),2022.
|
[13] |
Chawla Y,Duseja A,Dhiman RK. Review article:the modern management of portal vein thrombosis[J]. Aliment Pharmacol Ther,2009,30(9):881-894.
|
[14] |
Jiang GQ,Bai DS,Chen P,et al. Risk Factors for Portal Vein System Thrombosis After Laparoscopic Splenectomy in Cirrhotic Patients with Hypersplenism[J]. J Laparoendosc Adv Surg Tech A,2016,26(6):419-423.
|
[15] |
卢翔,赵青川,韩国宏,等. 肝硬化门静脉高压症术后门静脉血栓形成危险因素研究[J]. 中国实用外科杂志,2013,33(03):205-207.
|
[16] |
Ruiz-Tovar J,Priego P. Portal Vein Thrombosis After Splenic and Pancreatic Surgery[J]. Adv Exp Med Biol,2017,906:241-251.
|
[17] |
Lin WY,Lu X,Fan FJ,et al. Predictive Effect of Mean Platelet Volume in Patients with Portal Vein Thrombosis:A Meta-analysis of Case-control Studies[J]. Curr Med Sci,2018,38(4):575-581.
|
[18] |
Lu S,Hu G,Chen S,et al. Risk Factors of Portal Vein Thrombosis after Devascularization Treatment in Patients with Liver Cirrhosis:A Nested Case-Control Study[J]. Biomed Res Int,2020,2020:9583706.
|
[19] |
Sabbagh A,Keikhaei B,Joorabian M,et al. Retrospective study of the incidence of portal vein thrombosis after splenectomy in hematological disorders:Risk factors and clinical presentation[J]. Blood Cells Mol Dis,2019,74:1-4.
|
[20] |
Gardiner C,Pennaneac'h C,Walford C,et al. An evaluation of rapid D-dimer assays for the exclusion of deep vein thrombosis[J]. Br J Haematol,2005,128(6):842-848.
|
[21] |
Griesshammer M,Kiladjian JJ,Besses C. Thromboembolic events in polycythemia vera[J]. Ann Hematol,2019,98(5):1071-1082.
|
[22] |
Wei Y,Chen X,Shen H,et al. P-Selectin Level at First and Third Day After Portal Hypertensive Splenectomy for Early Prediction of Portal Vein Thrombosis in Patients With Cirrhosis[J]. Clin Appl Thromb Hemost,2018,24(9_suppl):76S-83S.
|
[23] |
Tripodi A,Primignani M,Chantarangkul V,et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis[J]. Gastroenterology,2009,137(6):2105-2111.
|
[24] |
De Gottardi A,Trebicka J,Klinger C,et al. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis[J]. Liver Int,2017,37(5):694-699.
|
[25] |
Kirkeby MH,Larsen JB,Grønbaek H,et al. Thrombophilia testing in patients with portal vein thrombosis[J]. Scand J Clin Lab Invest,2020,80(8):694-698.
|
[26] |
Tripodi A,Primignani M,Lemma L,et al. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis[J]. J Hepatol,2013,59(2):265-270.
|
[27] |
Kawanaka H,Akahoshi T,Kinjo N,et al. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism[J]. Ann Surg,2010,251(1):76-83.
|
[28] |
Wang L,Liu GJ,Chen YX,et al. Combined use of D-dimer and P-selectin for the diagnosis of splenic or portal vein thrombosis following splenectomy[J]. Thromb Res,2010,125(5):e206-e209.
|
[29] |
刘瑞红,廉恒丽. P-选择素和D二聚体对肝硬化门静脉血栓形成的早期预测价值[J]. 血栓与止血学,2021,27(06):974-976.
|
[30] |
Rottenstreich A,Kleinstern G,Spectre G,et al. Thromboembolic Events Following Splenectomy:Risk Factors,Prevention,Management and Outcomes[J]. World J Surg,2018,42(3):675-681.
|
[31] |
孙隆慈,徐庆. 不同术式对肝硬化门静脉高压症患者术后门静脉系统血栓形成的影响[J/CD]. 中华临床医师杂志(电子版),2013,7(11):4739-4743.
|
[32] |
Nephew LD,Goldberg DS. Impact of Anticoagulation on Upper Gastrointestinal Bleeding in Cirrhosis[J]. Gastroenterology,2016,150(5):1239-1241.
|
[33] |
Pettinari I,Vukotic R,Stefanescu H,et al. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis[J]. Am J Gastroenterol,2019,114(2):258-266.
|
[34] |
Sharma AM,Zhu D,Henry Z. Portal vein thrombosis:When to treat and how?[J]. Vasc Med,2016,21(1):61-69.
|
[35] |
Douketis JD,Spyropoulos AC,Spencer FA,et al. Perioperative management of antithrombotic therapy:Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest,2012,141(2 Suppl):e326S-e350S.
|
[36] |
Thachil J,Gatt A,Martlew V. Management of surgical patients receiving anticoagulation and antiplatelet agents[J]. Br J Surg,2008,95(12):1437-1448.
|
[37] |
戴朝六,徐锋,金添强. 重视门静脉高压症脾切除断流术后门静脉系统血栓的诊治[J/CD]. 中华普通外科学文献(电子版),2019,13(03):169-174.
|
[38] |
Smith A,Baumgartner K,Bositis C. Cirrhosis:Diagnosis and Management[J]. Am Fam Physician,2019,100(12):759-770.
|
[39] |
La Mura V,Braham S,Tosetti G,et al. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis[J]. Clin Gastroenterol Hepatol,2018,16(7):1146-1152.e4.
|
[40] |
Stotts MJ,Wentworth BJ,Northup PG. Management of Portal Vein Thrombosis in Cirrhosis[J]. Semin Liver Dis,2021,41(1):79-86.
|
[41] |
Wolter K,Decker G,Kuetting D,et al. Interventional Treatment of Acute Portal Vein Thrombosis[J]. Rofo,2018,190(8):740-746.
|
[42] |
Lombardo S,Espejo JJ,Pérez-Montilla ME,et al. The keys to successful TIPS in patients with portal vein thrombosis and cavernous transformation[J]. Radiologia(Engl Ed),2018,60(2):94-104.
|
[43] |
Weber A,Krebs S,Lenhardt C,et al. Correlation of routinely used coagulation parameters and presence of portal vein thrombosis in patients with liver cirrhosis[J]. Hepatol Res,2009,39(9):882-887.
|